This was a longitudinal single-center cohort study to comprehensively explore multimodal progression markers for Parkinson disease in patients with recently diagnosed PD and age-matched, neurologically healthy controls . Thirty tests at baseline and after 24 months covered nonmotor symptoms , cognitive function, and REM sleep behavior disorder by polysomnography , voxel-based morphometry of the brain by MRI, and CSF markers.